New York PFAS Lawsuit: Forever Chemicals in Your Drinking Water — What It Means for Your Family
You heard the news — New York’s Attorney General sued the chemical giants who put “forever chemicals” into the water your family drinks. You may have felt a flash of validation: someone is finally doing something. Then the harder question set in. What does this lawsuit actually mean for you — for the person in your house who was diagnosed with kidney cancer, the child born with a thyroid condition, the years of unexplained liver enzyme elevations your doctor could never quite explain? The Attorney General’s lawsuit is real, and it matters. But it is not your lawsuit. It does not automatically write you a check. It does not automatically order the medical monitoring your family may need. It does not compensate the wages lost to a disease that may trace back to the tap water you drank every day for a decade. Those are separate fights — and they are fights you have the right to bring. We are a trial firm that takes New York toxic tort cases, and this page is what we would tell you if you called us tonight, at 2 a.m., frightened and angry and trying to understand what comes next. Nothing here is a guess. Every rule, every number, every deadline is the law as it stands — and every honest limit is stated plainly, because you deserve the truth, not a sales pitch. If you want to talk to us after reading this, the call is free. 1-888-ATTY-911. We answer 24 hours a day.
What the New York Attorney General’s Lawsuit Actually Does — and What It Does Not Do for You
The Attorney General filed a 74-page complaint in Albany County Supreme Court against 3M Company, E.I. du Pont de Nemours and Company (DuPont), Chemours, Corteva, and EIDP. The state’s claims are powerful and broad: public nuisance, products liability for failure to warn, fraudulent concealment, design defect, unjust enrichment, and violations of New York’s Environmental Conservation Law. The state seeks court-ordered cleanup funding, damages, disgorgement of decades of profits, restitution for costs already borne by New York communities, and an injunction barring the companies from selling PFAS-containing products without adequate consumer warnings.
“As a result of defendants’ conduct, PFAS … are in the water we drink, the soil that sustains our crops, the fish we catch and the air we breathe.”
That is the language of the filed complaint — and it describes a contamination so complete that it has entered the food chain, the water table, and the air. But here is the distinction the news coverage did not draw clearly enough: the Attorney General represents the State of New York. The relief sought is for the state — cleanup costs, economic damages to public resources, disgorgement of corporate profits. If the state wins a multi-billion-dollar judgment or settlement, that money goes to remediation and to the state treasury. It does not automatically flow to the individual who drank contaminated water for fifteen years and was diagnosed with kidney cancer at forty-seven. That individual — you, your spouse, your child, your parent — has a separate legal claim that must be filed separately, by your own lawyer, on your own timeline, under your own cause of action. The AG’s lawsuit is a spotlight. It illuminates the conduct, forces document production, and establishes a public record of what these companies knew and when they knew it. But it is not a substitute for the claim you have the right to bring yourself. And the discovery that comes out of the state’s case — the internal memos, the suppressed health studies, the timeline of concealment — can become evidence in your individual case. That is why the AG’s action matters to you even though it is not your action. It builds the road. You still have to walk it.
What Are PFAS “Forever Chemicals” — and Why Are They in Your Water
PFAS stands for per- and polyfluoroalkyl substances — a family of thousands of synthetic chemicals characterized by one of the strongest chemical bonds in nature: the carbon-fluorine bond. That bond is what makes PFAS “forever.” It does not break down. Not in water, not in soil, not in sunlight, not in the human body. The same property that made these chemicals miracles of modern manufacturing — their extraordinary resistance to heat, water, oil, and stain — is what makes them an environmental and public health catastrophe. They persist. They accumulate. They travel.
For decades, PFAS were used in products virtually every American household owned. 3M’s Scotchgard line — the fabric and surface protector sprayed on couches, carpets, car interiors, and outdoor gear — contained PFAS. DuPont’s nonstick cookware line, beginning in the 1960s, used PTFE, a PFAS compound. DuPont’s Stainmaster carpet, sold nationally from 1986 to 2004, was treated with PFAS. Fabric treatments, weather-resistant paints, hair products, food packaging, firefighting foam — PFAS were everywhere because they worked. The problem is that they never stopped working. When a Scotchgard-treated couch was discarded, the PFAS leached into landfill runoff. When nonstick pans were washed, trace PFAS entered the wastewater stream. When firefighting foam was used at military bases, airports, and industrial facilities — including facilities across New York — the PFAS loaded into the foam seeped directly into groundwater. And from groundwater, PFAS moved into the reservoirs, aqueducts, and municipal systems that supply drinking water to roughly 20 million New York residents.
The contamination is not theoretical. New York’s drinking water infrastructure — including the New York City Delaware/Catskill/Croton watershed system, one of the largest unfiltered water supplies in the world — is vast and vulnerable. PFAS travel easily through water and air, accumulate over time in plants and animals, and concentrate in the human body with every exposure. A person who drank PFAS-contaminated water for ten years carries a body burden that does not decline meaningfully for years, even after exposure stops. That is the science the complaint describes when it says these chemicals are in “the water we drink, the soil that sustains our crops, the fish we catch and the air we breathe.” It is not rhetoric. It is chemistry.
Who Is Being Sued — the Corporate Web Behind the Contamination
The defendants in the New York lawsuit are not a single company or two. They are a deliberately constructed corporate family — and understanding that family is the first step in understanding who might be responsible for what is in your water.
3M Company manufactured and sold PFAS-containing Scotchgard products for decades. 3M was one of the original developers of PFAS chemistry and produced these compounds at industrial scale. The company is alleged to have known of the health risks and to have concealed them from the public and from regulators. 3M is a standalone corporate giant — no parent company hides behind it — but it carries enormous legal exposure, as demonstrated by its 2023 agreement to pay approximately $10.3 billion to settle a batch of similar pollution lawsuits funding a national cleanup of public water supplies.
E.I. du Pont de Nemours and Company (DuPont) is the original chemical giant that manufactured PFAS-containing nonstick cookware beginning in the 1960s and Stainmaster stain-resistant carpeting from 1986 to 2004. DuPont’s history with PFAS is long and deeply documented — the company’s internal knowledge of PFOA’s health effects, stretching back decades, has been the subject of extensive litigation, regulatory investigation, and public exposé.
Then comes the corporate restructuring — the part that matters most for understanding who actually holds the liability.
Chemours is a 2015 spinoff from DuPont. When DuPont created Chemours, it transferred certain PFAS-related liabilities and manufacturing operations to the new entity. In toxic tort litigation, this is the classic “spinoff holds the legacy liability” maneuver — the parent creates a new company, pushes the historical responsibility onto it, and then argues that the original parent’s balance sheet is insulated. Whether that insulation holds depends on the specific facts, the corporate agreements, and the legal theories pursued — but the structure itself is what plaintiffs must pierce.
Corteva is another DuPont spinoff, created from the DowDuPont merger and subsequent split. Corteva is named in the complaint as part of the corporate web that profited from PFAS products and inherited associated liabilities. The allocation of liability among DuPont, Chemours, and Corteva is governed by internal corporate agreements — agreements that the Attorney General’s discovery will surface and that individual plaintiffs’ counsel will also seek.
EIDP is a DuPont-related entity also named as a defendant. Its specific role and liability allocation are subjects for corporate-structure discovery — meaning the internal documents that show who owned what, who profited from what, and who agreed to shoulder which liabilities when the companies divided themselves up.
The practical point is this: the name on the product that contaminated your water may be “DuPont” or “3M,” but the legal entity that answers for that contamination may be a spinoff you have never heard of. In 2023, Chemours, DuPont, and Corteva collectively agreed to a $1.1 billion settlement resolving similar PFAS claims — a figure that tells you the liability is real, the money is present, and these entities do pay. But naming the right defendant, with the right theory, against the right corporate entity is foundational work. A complaint that names the wrong entity can collapse before the evidence is ever heard.
The Health Risks: What the Science Says About PFAS and Your Body
PFAS are not a mystery to the scientific community. They are among the most studied synthetic chemicals in the world, and the evidence of their health effects has been accumulating for decades.
The C8 Science Panel — a group of independent epidemiologists established as part of a legal settlement between DuPont and residents of the Mid-Ohio Valley who were exposed to PFOA-contaminated drinking water — conducted one of the most extensive PFAS health studies ever undertaken. In 2012, the panel found a “probable link” between PFOA and six health conditions: kidney cancer, testicular cancer, high cholesterol, thyroid disease, pregnancy-induced hypertension, and ulcerative colitis. Those findings are not speculative — they are the product of peer-reviewed epidemiological research conducted by independent scientists with access to years of health data from an exposed population.
The International Agency for Research on Cancer (IARC) — the world’s leading cancer-science authority, part of the World Health Organization — has classified PFOA as a Group 1 carcinogen (carcinogenic to humans) and PFOS as a Group 2B carcinogen (possibly carcinogenic to humans). IARC’s Group 1 classification is reserved for substances where the evidence of cancer-causing potential in humans is sufficient. PFOA joins that category alongside substances like asbestos, benzene, and tobacco smoke. This is not a lobbying position or a advocacy claim — it is the conclusion of an international scientific body that reviewed the totality of the evidence.
The New York AG’s complaint specifically alleges that PFAS exposure is linked to certain cancers, birth defects, liver disease, and other health problems. The broader scientific literature also associates PFAS exposure with immune system effects, decreased vaccine response, developmental effects in children, and hormone disruption. The mechanism is biologically plausible: PFAS are not metabolized or excreted by the human body in any meaningful way. They bind to serum proteins, concentrate in the liver and kidneys, and persist for years — in some cases, the human half-life of certain PFAS compounds is measured in years, not days. Every exposure adds to the body burden. The burden does not decline quickly. And the disease processes that PFAS can trigger — cancer, thyroid dysfunction, liver damage — are diseases with long latency periods, meaning the cancer you are diagnosed with today may have been seeded by the water you drank a decade or more ago.
There is an important honesty point here that we will not paper over. The science connecting PFAS to specific diseases is strong but evolving. The C8 Science Panel’s “probable link” findings are powerful — but “probable link” in the C8 context is a specific legal standard, not a guarantee that any individual’s cancer was caused by PFAS. In an individual legal claim, you must prove both general causation (PFAS can cause this disease) and specific causation (PFAS caused YOUR disease). The general causation evidence is increasingly strong. The specific causation proof is where the real fight happens — and it requires dose reconstruction, exposure history, medical records, and expert testimony. We will not tell you this is easy. We will tell you it is possible, and that the right evidence, built from the first day, is what makes it possible.
How PFAS Got Into New York’s Water — the Contamination Pathway
New York’s drinking water infrastructure is enormous. The state serves roughly 20 million residents through a vast network of reservoirs, aqueducts, and groundwater systems. The New York City watershed alone — the Delaware/Catskill/Croton system — is one of the largest municipal water supplies in the world. Upstate communities rely on groundwater wells, small municipal systems, and private wells that are particularly vulnerable to localized PFAS contamination from industrial sites, military installations, airports, and firefighting training facilities.
PFAS enter water systems through multiple pathways. Industrial discharge — from facilities that manufactured, used, or processed PFAS-containing products — sends the chemicals directly into surface water and groundwater. Wastewater treatment plants do not remove PFAS; the chemicals pass through standard treatment processes and re-enter the environment in treated effluent. Landfill leachate carries PFAS from discarded consumer products into groundwater. Firefighting foam — particularly aqueous film-forming foam (AFFF), used for decades at military bases, airports, and industrial fire training sites — is one of the most concentrated PFAS contamination sources. When AFFF is used or spilled, the PFAS load in the foam seeps directly into soil and groundwater, creating plumes that can travel miles and persist for generations.
The Attorney General filed the complaint in Albany County Supreme Court — New York’s trial-level court of general jurisdiction. Albany County is the natural venue for statewide environmental enforcement actions because it is the seat of state government. The Department of Environmental Conservation and the Department of Health — the two state agencies most deeply involved in PFAS sampling, regulation, and response — are headquartered there. This venue choice provides evidentiary and administrative continuity: the state’s own testing data, regulatory records, and agency expertise are geographically close to the courthouse where the case will be fought. For individual plaintiffs, venue will depend on where you live, where you were exposed, and where the defendants do business — but the Albany County filing signals that the state is treating this as a centralized, coordinated enforcement effort.
What New York Law Says — the Legal Framework for PFAS Claims
New York’s toxic tort framework draws on several bodies of law simultaneously, and understanding how they interact is essential to understanding what your individual claim might look like.
The statute of limitations. New York applies a three-year statute of limitations for personal injury and property damage claims under the state’s civil practice rules. For toxic exposure cases, the critical question is when the clock starts. The discovery rule — which holds that the clock begins not at the time of exposure but when the plaintiff discovered or reasonably should have discovered the injury and its cause — is potentially available for latent environmental injuries. This is the doctrine that matters most for PFAS claimants, because the gap between exposure and diagnosis can be years or decades. You may have been drinking contaminated water in 2008 and received a cancer diagnosis in 2023. The question of when you “should have known” the cancer was connected to PFAS in your water is the question that determines whether your claim is alive. We treat this as a live, case-specific issue — not a guarantee. Some states impose an outer deadline (a statute of repose) that can cut off a claim even before discovery. We will not tell you your claim is timely until we have examined your specific timeline against New York’s current rules.
Punitive damages. New York does not impose statutory caps on punitive damages. This is a significant advantage for plaintiffs in cases involving knowing concealment of health risks — which is exactly what the AG’s complaint alleges. If a jury finds that these companies knew PFAS was dangerous and concealed that knowledge while continuing to sell products containing it, punitive damages are available without a statutory ceiling. The complaint’s factual allegations — that the companies were fully aware of the chemicals’ risks, failed to warn consumers, and continued to minimize the risks even after announcing phase-outs — directly target the conduct that punitive damages are designed to punish.
Comparative fault. New York follows a pure comparative negligence framework, meaning your own share of fault reduces your recovery but never automatically bars it. In a PFAS context, the defense may try to argue that you contributed to your own exposure through lifestyle choices — but this is a weak defense in a water contamination case, where the exposure came through municipal water you had no reason to suspect and no practical ability to avoid.
The Martin Act. New York’s General Business Law includes the Martin Act, which grants the Attorney General expansive investigative and enforcement authority over fraudulent business practices. The AG’s office has leveraged this authority in environmental health matters — and the Martin Act’s broad reach is part of what makes the state’s enforcement action so potentially powerful. The Martin Act is the AG’s tool, not an individual plaintiff’s tool, but its enforcement produces evidence that individual plaintiffs can use.
New York’s Environmental Conservation Law provides the state with statutory authority to pursue remediation costs and penalties for contamination of state natural resources. This is the statutory backbone of the state’s claim — separate from the common-law nuisance and products liability theories.
The Federal Regulatory Floor — EPA, CERCLA, and TSCA
Federal regulation of PFAS has been evolving rapidly, and the current framework strengthens both the state’s enforcement case and individual plaintiffs’ claims by establishing that these chemicals are formally recognized as hazardous at the federal level.
EPA drinking water standards. In April 2024, the EPA finalized the first-ever federal Maximum Contaminant Levels for PFAS in drinking water. The MCL for PFOA and PFOS — the two most studied and most prevalent PFAS compounds — was set at 4.0 parts per trillion. To put that number in perspective: four parts per trillion is roughly the equivalent of four drops of water in twenty Olympic-sized swimming pools. The EPA also set the Maximum Contaminant Level Goal — the level at which there is no known or expected health risk — at zero. That means the federal government’s own health-based determination is that there is no amount of PFOA or PFOS in drinking water that is considered safe. The compliance deadline for these standards is 2029, though the EPA has proposed extending that to 2031. The 4.0 ppt standard for PFOA and PFOS remains the durable regulatory anchor — the number a jury can be told represents the federal government’s judgment about what is acceptable in the water you drink.
CERCLA hazardous substance designation. In May 2024, the EPA designated PFOA and PFOS as “hazardous substances” under the Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA) — the federal Superfund law. This designation, effective July 8, 2024, means that any entity that releases one pound or more of PFOA or PFOS in a 24-hour period must report that release to the National Response Center and state/local emergency authorities. More importantly for litigation, CERCLA liability is strict, joint-and-several, and retroactive — meaning a company can be held responsible for the entire cleanup cost even if it was only one of multiple contributors, and even for contamination that occurred decades before the rule existed. The defenses are narrow: act of God, act of war, or a third party’s act. “We followed the rules at the time” is not a CERCLA defense.
TSCA reporting. Under the Toxic Substances Control Act, the EPA finalized a rule requiring any person who manufactured or imported PFAS or PFAS-containing articles in any year since January 1, 2011, to report uses, production volumes, disposal, exposures, and known hazards. This rule forces manufacturers to compile and disclose what they know about their own products — including information that may be directly relevant to individual PFAS claims. The reporting window has been delayed multiple times, but the core retroactive-to-2011 reporting duty is in place.
New York’s own drinking water standards. New York’s Department of Health has implemented state-level maximum contaminant levels for PFAS in drinking water that are among the most stringent in the nation. These state-level standards create parallel regulatory obligations that strengthen the state’s nuisance and statutory claims — and they tell a jury that New York, independently of the federal government, has determined that even very low levels of PFAS in drinking water are unacceptable.
The Evidence Clock — What Records Exist and How Fast They Disappear
In a toxic tort case, evidence is everything. Unlike a car crash where the skid marks fade and the dashcam overwrites, the evidence in a PFAS case is a mix of corporate documents that may survive for decades and individual records that can disappear in months. Knowing what exists, who holds it, and how fast it can legally die is what separates a real case from a memory.
Internal corporate documents and communications regarding PFAS health studies and risk assessments. These are the crown jewels of any PFAS case — the internal memos, research reports, executive communications, and board-level briefings that show what these companies knew about PFAS toxicity and when they knew it. These documents are held by the defendants, subject to corporate retention policies and litigation holds. Decades-old documents may already be lost, degraded, or destroyed under routine retention schedules — but the AG’s case and existing MDL discovery have already surfaced a substantial body of internal corporate knowledge. In individual cases, the discovery produced in the state’s enforcement action and in the federal AFFF MDL can become evidence — but you need counsel who knows how to access and deploy it.
New York public water system PFAS sampling data and historical testing records. The state’s agencies — the Department of Health and the Department of Environmental Conservation — are actively collecting water system sampling data across New York. This data establishes the geographic extent, duration, and concentration of PFAS contamination. Historical data may be incomplete or inconsistently maintained, particularly for periods before PFAS testing became routine. But the current testing records are being built right now, and they are the map of who was exposed to what, where, and when. If you are considering a claim, understanding the testing data for your specific water system is foundational.
Historical PFAS manufacturing, formulation, and sales records by product line. These records link specific defendants’ products to contamination pathways and support disgorgement calculations. Corporate archives spanning 60 or more years are at risk of degradation, loss, or destruction over time. For individual plaintiffs, these records matter less than the water testing data and the medical records — but they are part of the fabric of the broader case.
Internal communications regarding PFAS phase-out decisions and chemical substitution strategies. The AG’s complaint alleges that even after announcing plans to phase out some PFAS compounds in the early 2000s, the companies continued to minimize the chemicals’ risks and, in some cases, merely replaced one PFAS variant with another. The internal communications about these decisions — emails, meeting minutes, strategic planning documents — are electronic and subject to retention cycle overwrites. Electronic communications are the most fragile category of corporate evidence; they can be purged on automated schedules unless a litigation hold freezes them. This is why the preservation demand is urgent — not because the documents are definitely going to be destroyed, but because the law allows their destruction on a schedule, and only a formal hold stops that clock.
Scientific and medical literature on PFAS toxicology and epidemiology. This evidence is stable and expanding — published research does not disappear, and the body of PFAS science is growing rapidly. This is not time-sensitive in the same way corporate emails are, but the evolving state of the science means that causation standards may shift as new studies are published. A case built on today’s science may be stronger or different tomorrow — which is another reason not to wait.
Your individual medical records and PFAS blood testing. These are the records that prove YOUR exposure and YOUR injury. Medical records are retained by providers on schedules that vary — hospital records may be kept for years, but clinic records and private practice records can be purged on shorter cycles. PFAS blood testing — which measures the concentration of specific PFAS compounds in your serum — is available through specialized laboratories and can establish your individual body burden. Blood testing is not a court requirement, but it is the most direct evidence of your personal exposure, and it should be obtained before evidence of exposure degrades. PFAS persist in blood for years, so the window is longer than it would be for a chemical that clears quickly — but the sooner testing is done, the more accurately it reflects your historical exposure.
The Corporate Defendant’s Playbook — How Chemical Companies Fight These Cases
In a PFAS personal injury case, the defense playbook is not the same as an auto insurer’s playbook. There is no friendly “just checking in” phone call, no quick settlement check with a release printed on the back. The defendants are multinational chemical corporations with armies of lawyers and decades of experience fighting exactly these cases. Here is what they do — and here is how each move is countered.
Play 1: General causation challenge. The defense argues that the science connecting PFAS to your specific disease is not strong enough to meet the legal standard for admissibility. They bring their own experts who testify that the evidence is “inconclusive” or “contested.” The counter is the growing body of peer-reviewed science — the IARC classification of PFOA as Group 1, the C8 Science Panel’s probable-link findings, the EPA’s zero health-based goal — combined with your own treating physicians’ testimony and a qualified expert who can walk a jury through the dose-response literature. General causation for kidney cancer and testicular cancer in relation to PFOA is on increasingly solid ground. For other conditions, the fight is harder but winnable with the right experts.
Play 2: Specific causation challenge. Even if the defense concedes that PFAS can cause your disease in general, they argue you cannot prove that PFAS — and not something else — caused YOUR specific cancer. They point to family history, diet, smoking, occupational exposures, or sheer bad luck. This is the hardest fight in any toxic tort case, and it is where many cases are won or lost. The counter is dose reconstruction — using your residential history, water system testing data, employment records, and PFAS blood testing to estimate your cumulative exposure — combined with medical evidence ruling out alternative causes and expert testimony tying your specific disease to your specific exposure level. This is not easy. It is the core of the work.
Play 3: Statute of limitations. The defense argues that you waited too long — that you “should have known” your disease was connected to PFAS years ago and the three-year clock has expired. The counter is the discovery rule: the clock starts when you knew or should have known both of your injury AND of its connection to PFAS exposure. For most people, the connection between their cancer and decades-old tap water was not something they could have known until the recent explosion of PFAS news, regulatory action, and scientific publication. But this is a case-by-case, fact-specific fight — and it is why we will not tell you “you have plenty of time” without first examining your timeline.
Play 4: Regulatory compliance defense. The defense argues that they followed all applicable regulations at the time of your exposure — that there were no PFAS drinking water standards in 2005, so how can they be blamed for contamination that was legal? The counter is twofold. First, CERCLA liability is strict and retroactive — compliance with other regulations is not a defense to hazardous substance liability. Second, the core of the AG’s complaint and of individual claims is not that the companies violated a specific drinking water standard — it is that they knew the chemicals were dangerous and concealed that knowledge. A company that knows its product causes cancer and hides that fact from the public has committed fraud, regardless of whether a specific numerical standard had been written into the Code of Federal Regulations yet.
Play 5: De minimis exposure. The defense argues that the amount of PFAS you were exposed to was too small to matter — that everyone has some PFAS in their blood, and yours is just background. The counter is your individual exposure evidence: water system testing data showing elevated PFAS concentrations in your specific supply, blood testing showing elevated serum levels, residential history establishing the duration of your exposure, and expert testimony establishing that your cumulative dose exceeds the threshold associated with increased disease risk.
What Your Case Could Be Worth — Honest Valuation
We will not tell you a number without knowing your facts. But we can tell you the framework, and we can give you the benchmarks that exist.
The state enforcement action. Comparable national settlements provide valuation anchors. 3M’s 2023 settlement of similar pollution lawsuits — funding a national cleanup of public water supplies — was approximately $10.3 billion. The separate DuPont/Chemours/Corteva settlement was approximately $1.1 billion. New York’s share, adjusted for the state’s population (roughly 20 million residents), water system scale, and contamination scope, could range from hundreds of millions to multiple billions. The state seeks cleanup funding, damages, disgorgement, and restitution — categories that can stack into enormous aggregate figures.
Individual personal injury claims. For New York residents with PFAS-linked diseases — kidney cancer, testicular cancer, thyroid disease, liver disease, ulcerative colitis, or pregnancy-related conditions — the potential individual claim value depends on injury severity, causation strength, medical monitoring needs, and whether the case is part of a class or aggregation. Based on comparable toxic tort settlements and the case value framework in the existing analysis, individual claims could range from approximately $100,000 at the low end to $5 million or more per claimant at the high end, depending on the injury, the exposure, and the strength of the specific causation proof. These are not guarantees — they are the ranges that the existing settlement frameworks and toxic tort verdict history suggest are plausible. Past results depend on the facts of each case and do not guarantee future outcomes.
Medical monitoring. Even for individuals who have not yet been diagnosed with a PFAS-linked disease, the cost of ongoing medical surveillance — regular blood work, kidney function testing, liver enzyme monitoring, thyroid panels, cancer screening at appropriate intervals — is a recognized category of damages in toxic tort cases. If you were exposed to elevated PFAS levels in your drinking water, the cost of monitoring your health for the diseases that exposure puts you at risk for is a real, quantifiable expense that the law may require the responsible companies to fund.
Punitive damages. New York does not cap punitive damages. In a case where the jury finds that the defendants knowingly concealed the health risks of PFAS while continuing to sell products containing them — which is exactly what the AG’s complaint alleges — punitive damages can be awarded on top of compensatory damages, with no statutory ceiling. The purpose of punitive damages is to punish conduct that is so egregious it warrants more than compensation — it warrants a financial penalty that changes behavior. The allegations in this case, if proven, are the textbook predicate for punitive damages.
What reduces value. Honest valuation means naming the weaknesses too. Specific causation is hard. Latency means the exposure that caused your disease may be decades old, and the evidence connecting the two may be circumstantial. If you have other risk factors for your disease — family history, occupational exposures, lifestyle factors — the defense will use them to shrink the value. If your PFAS blood levels are not elevated, the exposure evidence is weaker. If your water system’s testing data shows only modest PFAS concentrations, the dose reconstruction is harder. These are not case-killers. They are the terrain, and knowing the terrain is the first step in winning on it.
PFAS Blood Testing — What It Means and Why It Matters
PFAS blood testing — also called serum biomonitoring — measures the concentration of specific PFAS compounds in your bloodstream. It is the most direct way to establish your individual exposure to these chemicals. The test is available through specialized laboratories, including some that work with clinical providers and others that operate through research or public health programs.
Here is what blood testing does and does not do. It does establish that PFAS are present in your body and at what concentration. It does provide a baseline that can be compared to population averages and to levels associated with increased disease risk in the scientific literature. It does give your legal case the most individualized exposure evidence possible — not a guess about what was in your water, but a measurement of what is in your blood.
It does not tell you when you were exposed. It does not tell you which product or which water source caused your exposure. It does not diagnose a disease or predict whether you will develop one. And it does not, by itself, prove that PFAS caused any condition you may have been diagnosed with. It is one piece of the puzzle — but it is a powerful piece, because it is your piece. It is about you, not about a statistical population.
If you are considering a PFAS claim, blood testing should be done as early as practical. PFAS persist in the body for years — the half-life of PFOA in human serum is estimated at approximately two to four years, and PFOS at approximately three to five years — so the window for meaningful testing is longer than it would be for a chemical that clears quickly. But every year that passes, the levels decline, and the picture of your historical exposure becomes less sharp. Testing now gives you the best available snapshot of your cumulative body burden.
Comprehensive medical records are equally critical. If you have been diagnosed with a condition potentially linked to PFAS — kidney cancer, testicular cancer, thyroid disease, liver disease, ulcerative colitis, pregnancy-induced hypertension — your diagnostic records, treatment history, pathology reports, and physician notes are the evidence that establishes your injury. These records should be collected and preserved systematically. Hospital records may be retained for years, but clinic records and private practice records can be purged on shorter cycles. Do not assume your medical records will be there when you need them in three years — request them now.
The First Steps — What to Do If You Were Exposed to PFAS-Contaminated Water
If you have been drinking water from a system with documented PFAS contamination — or if you live in an area where PFAS testing has revealed elevated levels — and you have been diagnosed with a condition that may be linked to PFAS exposure, here are the practical steps that protect your health and your legal rights.
Get your medical records in order. Request complete copies of your diagnostic records, treatment history, lab results, imaging reports, and physician notes from every provider who has treated you for the condition in question. Do not settle for summary printouts — request the full chart. These records are the evidence of your injury, and they are subject to provider retention schedules that can result in their destruction after a set number of years.
Obtain PFAS blood testing. Contact a laboratory that performs PFAS serum analysis, or ask your physician to order the test. The results will establish your individual body burden — the most direct evidence of your personal exposure. Keep a copy of the results, the date of the test, and the laboratory’s reference materials.
Document your residential and employment history. Write down every address where you lived and the dates of residence, focusing on the water system that served each address. If you worked at a facility that used or produced PFAS-containing materials — a refinery, a chemical plant, a military base, an airport, a firefighting training facility — document your employment dates and job duties. This history is the backbone of your dose reconstruction.
Research your water system’s PFAS testing data. Contact your water utility or the New York Department of Health to request PFAS sampling results for your water system. If you are on a private well, consider having your water tested by a certified laboratory. The testing data establishes what was in your water and when — the other half of the exposure equation.
Do not sign anything from a chemical company, an insurance company, or anyone purporting to represent the defendants. If you receive a letter, a questionnaire, a settlement offer, or a release, do not sign it. Do not give a recorded statement. Do not answer questions about your health history or exposure over the phone. Anything you say can be used to diminish or deny your claim. If someone contacts you about your PFAS exposure, the correct response is: I need to speak with my attorney first.
Talk to a lawyer. Not because every exposure means a lawsuit — it does not. But because the deadline to file a claim is real, the evidence is perishable, and the defendants have lawyers who are already working to limit what they will have to pay. You should have someone working for you from the first day, not the last. The call is free. The consultation is free. We do not get paid unless we win your case.
Frequently Asked Questions
Can I sue 3M or DuPont for PFAS in my drinking water?
Yes — if you were exposed to PFAS-contaminated drinking water and have been diagnosed with a health condition linked to PFAS exposure, you may have an individual legal claim against the manufacturers. The Attorney General’s lawsuit is a separate enforcement action on behalf of the state; it does not prevent you from filing your own claim. Your claim would need to establish that you were exposed, that you suffered an injury, and that the exposure caused or contributed to your injury. The strength of your claim depends on the specifics of your exposure, your diagnosis, and the available evidence.
Does the Attorney General’s lawsuit mean I will automatically receive compensation?
No. The AG’s lawsuit seeks cleanup funding, damages, disgorgement, and restitution for the State of New York — not for individual residents. If the state obtains a settlement or judgment, the money goes to environmental remediation and the state treasury. Individual compensation requires an individual claim, filed by your own lawyer, on your own timeline. The AG’s case can produce evidence that helps your case — internal corporate documents, admissions, scientific findings — but it does not write you a check.
How long do I have to file a PFAS lawsuit in New York?
New York’s statute of limitations for personal injury claims is generally three years. For toxic exposure cases, the clock may not start until you discovered or reasonably should have discovered both your injury and its connection to PFAS exposure. This is called the discovery rule, and it is potentially available for latent environmental injuries in New York. However, the exact application of the discovery rule to PFAS claims is a case-specific legal question that depends on your individual timeline — when you were exposed, when you were diagnosed, and when you learned or should have learned about the connection. Do not assume you have plenty of time. Do not assume you are too late. Talk to a lawyer who can examine your specific facts against New York’s current rules.
What health conditions are linked to PFAS exposure?
The C8 Science Panel found probable links between PFOA and six conditions: kidney cancer, testicular cancer, high cholesterol, thyroid disease, pregnancy-induced hypertension, and ulcerative colitis. The IARC has classified PFOA as a Group 1 carcinogen (carcinogenic to humans) and PFOS as Group 2B (possibly carcinogenic). The broader scientific literature also associates PFAS with liver disease, immune system effects, decreased vaccine response, developmental effects in children, and birth defects. Not every condition has equally strong scientific support — the cancer links (particularly kidney and testicular) are the most established. We will not tell you your condition is linked to PFAS without examining the science behind your specific diagnosis.
How do I get tested for PFAS exposure?
PFAS blood testing — serum biomonitoring — is available through specialized laboratories. You can ask your physician to order the test, or contact a laboratory directly. The test measures the concentration of specific PFAS compounds in your blood serum. Results can be compared to population averages and to levels associated with increased disease risk in the scientific literature. Testing is most useful when done as early as practical, because PFAS levels in the body decline slowly over time once exposure stops.
What if I don’t have cancer but I’ve been drinking contaminated water?
You may still have a claim for medical monitoring — the cost of ongoing health surveillance to detect diseases that your PFAS exposure puts you at elevated risk for. Medical monitoring is a recognized category of damages in toxic tort cases. Even without a current disease diagnosis, the cost of regular blood work, kidney function testing, liver enzyme monitoring, thyroid panels, and appropriate cancer screening is a real, quantifiable expense that the law may require the responsible companies to fund. Whether you qualify depends on your exposure level, the contamination in your water system, and the applicable legal standards.
Were the companies aware of the health risks?
The Attorney General’s complaint alleges that the defendants “were fully aware of the chemicals’ risks” and “failed to warn consumers.” The complaint further alleges that even after announcing plans to phase out some PFAS compounds in the early 2000s, the companies “continued to shield consumers from the full scope of the chemicals’ risks” and, in some cases, “merely replaced one ‘forever chemical’ with another.” These are allegations — they have not been proven in court. But the historical record of PFAS litigation, including the DuPont/C8 cases and the internal documents that have surfaced in prior litigation, contains substantial evidence that at least some of these companies possessed internal knowledge of PFAS health risks decades ago.
What are the prior PFAS settlements?
In 2023, 3M agreed to pay approximately $10.3 billion to settle a batch of similar pollution lawsuits, funding a national cleanup of public water supplies. Separately, Chemours, DuPont, and Corteva agreed to a $1.1 billion settlement resolving similar claims. These settlements addressed water supplier contamination claims — they did not resolve individual personal injury claims. They provide valuation benchmarks for the scale of PFAS liability, but they are not direct payments to individuals and they do not guarantee what any individual claim is worth. Australia has also filed its own lawsuit against 3M seeking approximately $1.4 billion in damages related to PFAS in firefighting foams at military sites.
Is it too late to file a claim if I was exposed years ago?
Not necessarily. The discovery rule for latent injuries may mean your clock did not start until you learned or should have learned that your health condition was connected to PFAS in your drinking water. For many people, that connection only became apparent with the recent wave of PFAS news, regulatory action, and scientific publication. But this is a fact-specific question — your timeline, your diagnosis date, your water system’s testing history, and your own awareness of the issue all matter. Do not self-diagnose your deadline. Let a lawyer examine it.
How much does it cost to hire a PFAS lawyer?
We work on contingency. That means we do not charge an hourly fee. We advance the costs of the case — the expert witnesses, the document production, the filing fees, the testing — and we are paid only if we recover money for you. Our fee is 33.33% of the recovery before trial and 40% if the case goes to trial. If we do not win, you owe us nothing for our time. The initial consultation is free, and it is confidential. We serve families fully in English and in Spanish — Hablamos Español.
Why This Firm — Ralph Manginello and Lupe Peña
We are Attorney911 — The Manginello Law Firm, PLLC. We are a trial firm that takes New York toxic tort and catastrophic injury cases, working with local counsel and pro hac vice admission where required. We do not have an office in New York, and we will not pretend we do. What we have is 27 years of trial experience, a former insurance-defense attorney who knows how the other side values claims, and the resources to build the kind of case that PFAS litigation demands.
Ralph P. Manginello is our Managing Partner — 27 years licensed, admitted in Texas state and federal courts, including the U.S. District Court for the Southern District of Texas. Ralph was a journalist before he was a lawyer, which means he knows how to find the story the documents tell and how to present it to a jury in language they understand. He has spent his career in courtrooms, including federal court, fighting for people who were injured by the negligence and the choices of large corporations. If you want to understand how Ralph approaches a case, read his full background here.
Lupe Peña is our Associate Attorney — a former insurance-defense attorney who spent years inside a national defense firm, in the rooms where adjusters and their software decided how to deny, delay, and devalue people exactly like you. Lupe knows how the other side values claims because he used to be the other side. Now he uses that knowledge for injured clients. Lupe is fluent in Spanish and conducts full consultations in Spanish without an interpreter — if your family is more comfortable in Spanish, you can read about Lupe here, and you can talk to him in the language you trust most.
We handle toxic tort claims because the fight — corporate knowledge concealed, communities exposed, diseases with long latency that demand patient, meticulous, evidence-driven work — is the kind of fight that rewards exactly the preparation and persistence our firm was built on. If you have lost a family member to a PFAS-linked disease, we also handle wrongful death claims — because the companies that contaminated your water should answer for the lives that contamination took, not just the water it ruined.
You can reach us at 1-888-ATTY-911. The call is free. The consultation is free. We do not get paid unless we win your case. We answer 24 hours a day — not an answering service, but live staff who can take your information and get you to a lawyer. And if we are not the right fit for your case, we will tell you that honestly and point you toward someone who is.
Past results depend on the facts of each case and do not guarantee future outcomes. This page is legal information, not legal advice. Contacting the firm is free and confidential. Hablamos Español.